ClinicalTrials.govpublic full text
DISKUS vs. ELLIPTA Device Preference Study in Chronic Obstructive Pulmonary Disease (COPD)
pulmonary disease, chronic obstructive, fluticasone furoate, copd, ellipta, fluticasone propionate, diskus, novel dry powder inhaler (ndpi), device preference, salmeterol, vilanterol, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 969357
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.